Are large in comparison with present-day cefepime breakpoints, greater breakpoints of cefepime/zidebactam might be warranted for Acinetobacter The steadiness of cefepime in opposition to AmpC, when coupled with an ESBL-active BLI, supplies the coverage of AmpC and ESBL coproducers, that are increasingly witnessed. Cefepime mixtures with BLIs having carbapenemase inhibitory https://lloydw222pbm7.wikifordummies.com/user